If this SPL has inactivated NDCs listed through the FDA initiated compliance motion, they will be specified as such.Phenobarbital is contraindicated in people who are hypersensitive to barbiturates, in individuals having a history of manifest or latent porphyria, As well as in clients with marked impairment of liver perform or respiratory disease i